Novichok is a class of military-grade nerve agents developed in the former Soviet Union between the 1970s and 1990s, designed to be more potent and harder to treat than earlier chemical weapons like sarin or VX.1PubMed Central. Novichoks: The Dangerous Fourth Generation of Chemical Weapons The name translates from Russian as “newcomer,” and the agents belong to the broader organophosphate family, the same chemical group that includes common pesticides.2PubMed Central. Novichok agents: a historical, current, and toxicological perspective What sets Novichok apart from its predecessors is a combination of extreme toxicity, unusual persistence in the environment, and a stubborn resistance to the medical antidotes that work against other nerve agents. These properties pushed Novichok from an obscure Cold War secret into global headlines after its use in the 2018 Salisbury poisoning and the 2020 poisoning of Russian opposition figure Alexei Navalny.
What Novichok Actually Is
Novichok is not a single chemical compound but a family of related agents, often referred to as the A-series. The best-known variants include A-230, A-232, A-234, A-242, and A-262. They are all organophosphorus compounds, meaning their molecular backbone centers on phosphorus bonded to organic groups. Within that family, though, there are meaningful structural differences. A-230 and A-242, for instance, are classified as phosphonates, placing them in the same chemical subgroup as VX. Meanwhile A-232, A-234, and A-262 are phosphates, a distinction that affects how volatile each agent is and how it behaves once it enters the body.3Food and Chemical Toxicology. Review 4th generation of warfare agents – Novichoks: Threats, problems, challenges for the security of the armed forces and civilian population
Their toxicity is often described as several times greater than VX, which was already considered the most dangerous classical nerve agent. That claim traces largely to statements by Vil Mirzayanov, the Russian chemist who first disclosed the program to the public. It is worth noting, however, that no published experimental research has fully confirmed these comparative potency figures under controlled laboratory conditions.4PubMed Central. Review of Possible Therapies in Treatment of Novichoks Poisoning and HAZMAT/CBRNE Approaches: State of the Art. What researchers do know from in vitro and computational work is that among the documented Novichok variants, A-232 stands out as the most toxic and the most potent inhibitor of the enzyme these agents target.5PubMed Central. AHAK: a new effective medical countermeasure against percutaneous intoxication by Novichok chemical warfare agents
How Novichok Attacks the Nervous System
Like all nerve agents, Novichok works by shutting down a specific enzyme in the body called acetylcholinesterase, often shortened to AChE. This enzyme has one critical job: it breaks down a chemical messenger called acetylcholine after that messenger has delivered its signal between nerve cells. Every time you move a muscle, take a breath, or feel your heart beat, acetylcholine is part of the signaling chain making it happen. Once the signal is sent, AChE quickly clears it away so the nerve can reset and fire again.
Novichok binds to the active site of AChE and locks it in an irreversible grip.6PubMed Central. What do we currently know about Novichoks? The state of the art. With the enzyme blocked, acetylcholine floods the junctions between nerves and muscles, between nerves and glands, and within the brain itself. The result is uncontrolled, continuous stimulation. Muscles contract and cannot relax. Glands secrete uncontrollably. The diaphragm, the muscle responsible for breathing, can lock up or go into spasm. Without intervention, the victim suffocates.
Computational modeling has shed some light on why Novichok agents bind so tightly. Researchers simulating how these molecules interact with the AChE active site found that Novichok agents sit much closer to the critical part of the enzyme than acetylcholine does. They also make contact with more of the surrounding amino acid residues, and those contacts are considerably stronger. For A-234, the binding energy was roughly 75 percent stronger than what acetylcholine achieves, and some of the amino acids that Novichok agents latch onto are ones that acetylcholine does not interact with at all.7PubMed Central. Novichok Nerve Agents as Inhibitors of Acetylcholinesterase—In Silico Study of Their Non-Covalent Binding Affinity This helps explain why the bond is so hard to break.
Symptoms of Exposure
Novichok poisoning produces what clinicians call a cholinergic crisis, the same broad syndrome seen in severe pesticide poisonings, because both involve organophosphate compounds attacking the same enzyme. The specific symptoms depend on the dose, the route of exposure (skin contact, inhalation, or ingestion), and how quickly treatment begins, but the progression follows a recognizable pattern.
Early signs involve the body’s glands and smooth muscles going into overdrive:
- Eyes: pinpoint pupils (miosis), blurred vision, eye pain
- Airways: excessive mucus and fluid production in the lungs, wheezing, chest tightness
- Digestive system: nausea, vomiting, diarrhea, abdominal cramping
- Skin and glands: profuse sweating, drooling, tearing
- Heart: slowed heart rate (bradycardia)
As poisoning progresses, skeletal muscles begin to twitch uncontrollably (fasciculations), followed by weakness and eventually paralysis. In severe cases, the muscles of respiration fail. The brain, flooded with acetylcholine, can produce confusion, seizures, loss of consciousness, and coma. Death, when it occurs, is typically from respiratory failure: a combination of airway flooding, paralysis of the diaphragm, and collapse of the brain’s breathing centers.
In the 2018 Salisbury incident, both of the initial victims required advanced life support on the first night, including multi-organ support and repeated doses of antimuscarinic drugs to counteract dangerously slow heart rates.8British Journal of Anaesthesia. Chemical, biological, radiological, and nuclear mass casualty medicine: a review of lessons from the Salisbury and Amesbury Novichok nerve agent incidents Their survival required weeks of intensive care.
Why Novichok Is So Hard to Treat
The standard emergency treatment for nerve agent poisoning relies on two drugs: atropine, which blocks the effects of acetylcholine at certain receptor sites, and an oxime reactivator (most commonly pralidoxime or obidoxime), which attempts to pry the nerve agent off the AChE enzyme and restore its function. Atropine can help manage the crisis by reducing secretions and stabilizing the heart rate, but it does not actually fix the underlying problem. The oxime is supposed to do that.
With Novichok, the oxime part of the treatment is where things break down. Studies examining how well commercially available oximes work against A-234, the agent used in the Skripal poisoning, found that none of them showed meaningful reactivation of the enzyme within the first ten minutes. Extended laboratory incubation over 24 hours revealed that only a handful of experimental oximes managed to restore even a modest fraction of enzyme activity, with HLö-7 and MMB-4 performing best, but these are not widely available clinical tools.9PubMed. Reactivation screening of A-234-inhibited human recombinant acetylcholinesterase in vitro Even those that showed some effect required hours of contact time, a timeline that is irrelevant in an emergency room where a patient is suffocating.
The situation with other Novichok variants is no better. Computational analysis of commercial oximes against A-242-inhibited AChE concluded that the drugs could not even properly approach the part of the enzyme that needs to be freed, suggesting they would have limited real-world effectiveness.10PubMed. Theoretical assessment of the performances of commercial oximes on the reactivation of acetylcholinesterase inhibited by the nerve agent A-242 (novichok) And A-232, the most toxic of the family, is also the most resistant to oxime reactivation, making it the most challenging variant to treat.5PubMed Central. AHAK: a new effective medical countermeasure against percutaneous intoxication by Novichok chemical warfare agents
This resistance to standard antidotes is one of the key reasons Novichok is considered qualitatively different from earlier nerve agents. With sarin or VX, oxime therapy can be genuinely life-saving if administered quickly enough. With Novichok, the medical team is left relying almost entirely on supportive care: mechanical ventilation, atropine to manage symptoms, anticonvulsants for seizures, and time.
Environmental Persistence
One of the more unsettling properties of certain Novichok agents is how long they can linger in the environment. All organophosphate nerve agents eventually break down when exposed to water, a process called hydrolysis. But the rate at which Novichok agents hydrolyze varies enormously depending on the specific compound, the pH of the surroundings, and the surface they are on.
A-234, the agent confirmed in the Salisbury attack, has a half-life of roughly 10 to 30 days at neutral pH. That makes it about 20 to 50 times slower to break down than other A-series agents, about 80 times slower than VX, and about 2,000 times slower than sarin.11Talanta Open. Detection and analytical challenges of Novichok nerve agents: A review from the perspective of the Navalny and Skripal cases This persistence was dramatically demonstrated in the Salisbury case itself, where traces of A-234 were detected on contaminated surfaces months after the initial deployment.
On porous materials like fabric, soil, and certain building surfaces, Novichok agents may persist even longer than those half-life figures suggest, because porous matrices shield the agent from the moisture that drives hydrolysis. This is what made the Amesbury incident possible: a discarded perfume bottle containing A-234 was found by a member of the public months after the Skripal attack, leading to a second round of poisonings including one fatality.
Hydrolysis is also heavily pH-dependent. Computational studies of A-230, A-232, and A-234 under varying pH conditions found that the half-life follows a characteristic bell-shaped curve. Breakdown is fastest under strongly acidic or strongly basic conditions and slowest near neutral pH, which unfortunately is close to the conditions found in most natural environments.12PubMed Central. Hydrolysis mechanisms for A-series (Novichok) nerve agents at different pH V and computational simulant screening
Decontamination Challenges
The environmental resilience of Novichok agents makes decontamination a serious practical problem. After the Salisbury incident, entire sections of the city had to be scrubbed, and some structures were effectively demolished because confident decontamination could not be guaranteed.
Laboratory research on the neutralization of A-234 using different chemical decontaminants found wide variation in how quickly they could destroy the agent. Three decontaminant formulations were tested: an alkaline potassium hydroxide solution in ethanol, a commercial decontaminant called GDS-2000, and a deep eutectic solvent called Biodecon-83. The total time required to fully eliminate detectable A-234 ranged from 5 hours for the fastest-acting solution to 44 hours for the slowest.13Journal of Chromatography Open. Characterization of hydrolysis products and determination of the rate of hydrolysis of Novichok A-234 in different decontaminants The good news from that research was that all the breakdown products were considerably less toxic than the parent compound. But even five hours of required contact time is a long wait when contaminated surfaces are in a public area.
For first responders and military personnel, the practical takeaway is that simply washing a surface with water or mild soap is unlikely to be sufficient. Effective Novichok decontamination requires strongly alkaline or specialized chemical solutions applied for extended periods, and confirming that the agent has been fully neutralized requires analytical equipment that is not available outside of specialized labs.
How Forensic Teams Detect Novichok
Identifying that a poisoning involves a Novichok agent rather than another organophosphate is analytically difficult. The agents themselves are present in vanishingly small quantities at a crime scene, and because they degrade over time, forensic teams are often searching for breakdown products rather than the original compound.
One approach uses a technique called hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry to detect Novichok degradation products in human urine. This method can identify six different breakdown products at concentrations as low as 1 to 50 nanograms per milliliter.14PubMed Central. Analysis of degradation products of Novichok agents in human urine by hydrophilic interaction liquid chromatography–tandem mass spectrometry That sensitivity matters because the metabolites present in a victim’s urine can be the primary evidence linking a poisoning to a specific agent.
Another method tackles the problem from the environmental side, detecting the parent agents themselves (A-230, A-232, and A-234) at trace levels in water, soil, blood plasma, and urine. Researchers developed a chemical derivatization step that converts the agents into a form that is easier for instruments to detect, pushing detection limits down to 0.05 to 0.1 nanograms per milliliter.15PubMed. Derivatization-Assisted Sensitive Detection of Novichok Agents by Gas Chromatography-Mass Spectrometry for the Verification of Environmental and Biomedical Samples A separate technique using a different derivatization chemistry achieved a similar improvement, with detection limits one to two orders of magnitude better than prior methods, and was designed specifically for biological fluid samples.16PubMed. Advances in Derivatization Techniques Enabled by DABCO for Novichok Agent Analysis in Biofluids Using LC-MS
These analytical advances are driven in part by the requirements of the Chemical Weapons Convention, which mandates that any accusation of chemical weapons use be backed by laboratory-confirmed identification of the agent or its unique breakdown products. The Novichok program’s long secrecy meant that reference standards, the pure samples needed to calibrate detection instruments, were essentially unavailable to Western laboratories until very recently. The fact that forensic teams were able to identify A-234 in both the Skripal and Navalny cases reflects a significant acceleration in analytical capability over just a few years.
The Organophosphate Family Tree
Novichok agents did not emerge from nowhere. They are the latest branch on a long and troubling family tree of organophosphorus compounds that stretches back to the development of insecticides in the 1930s and 1940s. The first nerve agents, the G-series (tabun, sarin, soman), were discovered in Germany before and during World War II, originally as byproducts of pesticide research. The V-series (including VX) followed in the 1950s, developed in Britain and later weaponized in the United States and Soviet Union. Novichok represents what is sometimes called the fourth generation, developed specifically to be more lethal than VX while also evading detection by NATO’s chemical defense equipment of that era.17PubMed Central. History of Organophosphorus Compounds in the Context of Their Use as Chemical Warfare Agents
This shared lineage with agricultural chemicals is not just a historical footnote. The symptoms of Novichok poisoning are clinically identical to those of severe pesticide poisoning, because the mechanism is the same. Emergency physicians treating agricultural organophosphate exposure routinely manage the same cholinergic crisis, with the same drugs and the same challenges around respiratory support.18Journal of MedVerse Research & Practice. Series of Acute Organophosphate Poisoning Cases in Agricultural Workers The critical difference is one of scale and stubbornness: Novichok agents are effective at far lower doses and resist the antidotes that can successfully reverse pesticide poisoning.
The dual-use nature of organophosphorus chemistry, where the same basic reactions that produce crop-protecting insecticides can be tweaked to produce nerve agents, is one reason the Chemical Weapons Convention devotes extensive attention to precursor chemicals. Some of the raw materials that could theoretically be used to synthesize Novichok agents are also used in legitimate industrial and agricultural processes, making verification and enforcement a persistent challenge for international inspectors.
What Researchers Are Working On Now
The demonstrated failure of standard oximes against Novichok has pushed researchers toward designing new molecules specifically tailored to this class of agents. The search takes two forms: developing next-generation oxime reactivators that can reach the blocked enzyme site even when classical ones cannot, and exploring entirely different therapeutic strategies such as bioscavengers (enzymes that intercept the nerve agent in the bloodstream before it reaches AChE) or novel small molecules that work through alternative mechanisms.
Recent animal research has explored combination therapies designed for skin-exposure scenarios, which are the most likely route in a real-world Novichok attack. One study tested a formulation called AHAK against percutaneous (through-the-skin) exposure to Novichok agents, targeting specifically the challenge posed by A-232, the most resistant variant.5PubMed Central. AHAK: a new effective medical countermeasure against percutaneous intoxication by Novichok chemical warfare agents The fact that this research is appearing in open literature reflects a notable shift. For decades, Novichok agents existed in a kind of scientific shadow: their existence was known, but almost no independent research could be conducted on them because Western labs lacked samples, reference standards, and political authorization. That has changed dramatically since 2018, and the pace of published research on Novichok detection, treatment, and decontamination has accelerated substantially.
The research gap remains real, though. Most of what is known about Novichok toxicity in living organisms comes from a small number of studies using animal models or computational simulations. Human data is limited to the handful of confirmed poisoning cases, each of which involved chaotic field conditions rather than controlled observation. The pharmacokinetics of these agents, how quickly they are absorbed, distributed, metabolized, and excreted by the human body, remain incompletely understood. Filling those gaps is essential for developing effective medical countermeasures, but it is inherently limited by the ethical impossibility of controlled human exposure studies and the extreme hazards of working with these compounds even in a laboratory setting.